Anna Abolian

Company: REGENXBIO

Job title: Medical Director, Clinical Development

Seminars:

Workshop A: Unlocking the Potential of the Suprachoroidal Space to Deliver Durable Ophthalmic Therapies 9:00 am - 12:00 pm

Suprachoroidal delivery is an emerging and exciting alternative administration route to increase the durability of different ophthalmic therapies. The recent FDA approval of the first therapeutic delivered into the suprachoroidal space is leading the charge of an array of ongoing preclinical and clinical developments using suprachoroidal delivery for a range of ophthalmic modalities and indications.…Read more

day: Pre-Conference Workshop Day

Assessing Current Clinical Developments in Ophthalmic AAV Vector Gene Therapies Delivered by Subretinal and Suprachoroidal Injection 10:45 am

Exploring the technological background of therapies in development Evaluating the progress of ongoing clinical trials Addressing existing unmet clinical needs in target disease areasRead more

day: Day Two